Harpoon Therapeutics
IPO News: UPDATE - Harpoon Therapeutics Prices 5.4mm Share IPO at $14, at the midpoint of the $13.00 - $15.00 Marketing Range
Harpoon Therapeutics

Harpoon Therapeutics

NASDAQ: HARP

Initial Filing Date: 12/28/19

Launch Date: 01/29/19

Pricing Date: 02/08/19

IPO Price: $14.00

Price Range: $13.00 - $15.00

Initial Shares Offered (mm): 5.4

Shares Offered (Pre-Shoe | mm): 5.4

Primary Shares (mm): 5.4

Secondary Shares (mm): 0.0

Amount Offered (mm):    $75.6

% Secondary: 0.0%

Shares Outstanding (mm): 23.9

Market Value at Pricing (mm):      $334.7

Offering as % of Market Value:    22.6%

Bookrunners: CITI | LEER

Co-Managers: Canaccord | Wedbush

Major Holders:   MPM Capital | UBS Oncology Impact Fund | New Leaf Ventures | Arix Bioscience | OrbiMed

Industry: Healthcare

Description: Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases

Note: Emerging Growth Company

Reference Link: Press release